Introduction {#Sec1}
============

Interactions between fungi and bacteria occur in many ecological contexts and can range from mutualistic to antagonistic \[[@CR1], [@CR2]\]. As fungi and bacteria are the main decomposers of plant-derived dead organic matter, they are competitors for nutrients in such niches \[[@CR3], [@CR4]\]. Fungi defend their niche mainly chemically i.e., by production and secretion of antibacterials \[[@CR5]\]. Such defense effectors range from secondary metabolites (natural products) to peptides and proteins and are not essential for the viability of the fungus under axenic conditions \[[@CR6]--[@CR8]\]. It is well established that the biosynthesis of these compounds in fungi is regulated in response to external and internal signals but the significance and the molecular mechanisms of this regulation are not well understood \[[@CR9]\]. A deeper understanding of these issues will help to explore the hidden arsenal of fungal defense effectors e.g., for the discovery of new antibiotics \[[@CR10]--[@CR12]\].

In plants, whose primary defense is also chemical, the productions of defense effectors is either developmentally regulated, leading to tissue-specific expression patterns, or induced upon challenge with antagonists \[[@CR13]\]. Whereas developmental regulation is thought to provide specific tissues with preventive protection against the most abundant antagonists, inducible defense enables the plant to save resources by omitting the production of defense effector molecules in the absence of antagonists and by tailoring its defense to a specific type of antagonist. Such an inducible defense system requires specific receptors for recognition of and differentiation between different antagonists and signaling pathways downstream of these receptors leading to transcriptional activation of genes coding for defense effectors against the respective antagonist \[[@CR14]\].

Tissue-specific production has been reported for fungal defense effectors. For example, production of a Csαβ-defensin, which is mainly active against Gram-positive bacteria, and two isolactonases cleaving typical quorum sensing molecules of Gram-negative bacteria, is restricted to vegetative mycelium and does not occur in the fruiting bodies of axenically cultivated mushroom *Coprinopsis cinerea* \[[@CR15], [@CR16]\]. Conversely, various genes coding for nematotoxic lectins and insecticidal protease inhibitors are preferentially expressed in the fruiting body of *C. cinerea* and many other mushrooms \[[@CR17], [@CR18]\]. The expression pattern of these defense effectors is in accordance with the ecology of *C. cinerea*, as the vegetative mycelium of this coprophilous fungus is mainly exposed to bacterial competitors and parasites, whereas the fruiting bodies are mainly under attack of animal predators \[[@CR8]\]. In addition to this constitutive defense of specific tissues, there is increasing evidence that fungi are also able to respond to the presence of specific antagonists through the upregulation of respective defense effectors. For example, upon challenge of the vegetative mycelium with a fungivorous nematode, *C. cinerea* induced the production of nematotoxic lectins that were not produced under axenic conditions or upon challenge with bacteria under the same condition \[[@CR19], [@CR20]\]. While these studies lack the experimental evidence that this response is physiologically significant for the fungus, other studies show that upregulation of secondary metabolite biosynthesis in the mold *Aspergillus nidulans* in response to grazing by a soil arthropod leads to deterrence of the arthropod \[[@CR21], [@CR22]\]. These results suggest that fungi are able to respond to animal predators by mounting specific defense responses that directly affect the antagonist and are involved in securing fungal growth and propagation. Thus far, experimental evidence for an analogous, specific fungal defense response against bacterial competitors is poor. Although various interaction studies between fungi and bacteria report the induced expression of fungal genes coding for secondary metabolites and other putative defense effectors, the produced molecules either have not been characterized for antibacterial activity or did not show activity in such assays \[[@CR23]--[@CR30]\]. The most compelling evidence for a specific defense response of fungi against bacteria comes from two recent reports on the induced production of antibacterial depsipeptides, in the marine-derived mold *Emericella* sp. upon cocultivation with a marine actinomycete \[[@CR31]\] and in the fungal endophyte *Fusarium tricinctum* upon cocultivation with *B. subtilis* \[[@CR32]\]. These studies do not include any analysis of fungal gene expression, however.

In this study, we confronted the coprophilous model fungus *C. cinerea* with the Gram-negative and Gram-positive model bacteria, *Escherichia coli* and *Bacillus subtilis*, respectively, in a previously employed semi-liquid setup \[[@CR15]\]. We investigated the response of the fungus to the bacteria through comparative transcriptomics, as well as comparative proteomics of the secretome. Analysis of the differentially expressed *C. cinerea* genes upon exposure to either of the bacteria revealed an overlapping set of highly induced genes. In line with a putative role in the extracellular interaction with bacteria, an overrepresentation of genes coding for secreted proteins was found among these induced genes. Moreover, for many induced genes, putative antibacterial activity could be attributed to the encoded proteins based on the in silico identification of conserved domains. These proteins included a paralog of the previously identified Csαβ-defensin Copsin, as well as members of a yet uncharacterized family of proteins containing a conserved defensin-like domain linked to a GH24-type lysozyme (phage lysozyme) domain \[[@CR15], [@CR33]\]. Importantly, the predicted antibacterial function of these proteins could be confirmed and characterized through antibacterial assays using heterologously produced proteins. Altogether, the presented results provide evidence for the presence of an inducible defense mechanism in *C. cinerea* against Gram-negative and Gram-positive bacteria.

Materials and Methods {#Sec2}
=====================

Strains, culture media and chemicals {#Sec3}
------------------------------------

*C. cinerea* AmutBmut (A43mut B43mut pab1.2) \[[@CR34]\] and *Pichia pastoris* (NRRLY11430) were used for all experiments involving a fungus. *E. coli* (Nissle 1917) and *B. subtilis* (NCIB 3610) \[[@CR35]\] were used as model bacterial competitors. *E. coli* (DH5α) was used for cloning purposes throughout this study. *C. cinerea* was cultivated on YMG (0.4% (w/v) yeast extract (Oxoid), 1% (w/v) malt extract (Oxoid), 0.4% (w/v) glucose, 1.5% (w/v) agar), *P*. *pastoris* on YPD (1% (w/v) yeast extract, 2% (w/v) bacteriological peptone (Oxoid), 2% (w/v) glucose, 1.5% (w/v) agar) and the bacteria on Luria Bertani (LB) agar plates (0.5% (w/v) yeast extract, 1.0% (w/v) tryptone, 0.5% (w/v) sodium chloride, 1.5% (w/v) agar). Transformants of *P. pastoris* and *E. coli* DH5α were selected and maintained on media containing either 100 mg/l or 30 mg/l of Zeocin (LabForce), respectively. The bacterial strains used for the antibacterial activity assays and their specific cultivation conditions are mentioned below. If not mentioned otherwise, all chemicals were bought at the highest available purity from Sigma-Aldrich.

*C. cinerea* co-cultivation with bacteria and preparation of RNA {#Sec4}
----------------------------------------------------------------

Fungal-bacterial co-cultivation on glass beads was performed as previously described \[[@CR15]\]. In brief, the bottom of a Petri dish (10 cm diameter) was covered with borosilicate glass beads (5 mm diameter), submerged in 12 mL *C. cinerea* minimal medium (CCMM). Three plugs were cut from the margin of a *C. cinerea* mycelial colony, that had been previously cultivated on YMG agar plates at 28 °C for 3 days, and placed on top of glass beads. The fungal cultures were incubated in a humid chamber at 28 °C for 2.5 days in the dark. *E. coli* Nissle 1917 and *B. subtilis* NCIB 3610 \[[@CR35]\], precultivated on LB agar plates, were cultivated in CCMM liquid medium to an optical density (OD~600~) of 0.3. The cells were collected by centrifugation to remove the culture medium, resuspended in 0,5 ml culture medium taken from the individual *C. cinerea* plates and added to the respective *C. cinerea* glass beads plates at an OD~600~ of 0.1. *C. cinerea* cultures were also left untreated for axenic controls.

All cultivations were performed in triplicates and incubated at 28 °C for 8 h in the dark. Subsequently, the mycelium was harvested and flash frozen in liquid nitrogen. After lyophilizing the mycelium, 1 mL of Qiazol (Qiagen) and glass beads (0.5 mm diameter) were added and cells were lyzed using a FastPrep (Thermo Scientific) device (three cycles for 30 sec at level 5.5 m/s with cooling the samples for 3 min on ice in between the cycles). Total RNA was extracted using the RNeasy Lipid Tissue Mini Kit (Qiagen) according to the manufacturer's protocol.

RNA library construction and sequencing {#Sec5}
---------------------------------------

RNA quality control and concentration were assessed using the Bioanalyzer 2100 (Agilent) and Qubit (1.0) fluorometer (Life Technologies), respectively. Transcriptome library preparation (TruSeq Stranded RNA Kit), cDNA sequencing (Illumina HiSeq™ 2500), and data pre-processing were performed at the Functional Genomics Center Zurich (FGCZ) following manufacturers' protocols. Data analysis was performed using SUSHI \[[@CR36]\], an NGS data analysis workflow management system developed by the FGCZ, which supports selected open source NGS data analysis packages. In detail, reads were aligned with STAR aligner \[[@CR37]\] with the additional options (\--outFilterMatchNmin 30 \--outFilterMismatchNmax 5 \--outFilterMismatchNoverLmax 0.05 \--outFilterMultimapNmax 50) which means that at least 30 bp matching was required, and accepted were at most 5 mismatches, and at most 5% of mismatches. Alignments were only reported for reads with less than 50 valid alignments with the genome. The *C. cinerea* AmutBmut pab1-1 genome (2013-07-19) and its annotation v1.0 (2016-09-12, filtered gene models) from the US Department of Energy (DOE) Joint Genome Institute (JGI) were used as reference \[[@CR38]\]. Expression counts were computed using the featureCounts from the Bioconductor package subread \[[@CR39]\]. Differential expression was computed using the DESeq2 package \[[@CR40]\]. The RNA data is deposited in the ArrayExpress database under the accession number E-MTAB-6876.

Genome-wide analysis of differential gene expression {#Sec6}
----------------------------------------------------

*C. cinerea* genes that displayed increased expression in the bacteria-treated samples compared to the control samples were considered significantly induced using criteria of a log 2 fold change (FC) ≥ 2, a *P*-value \< 0.005 and a false discovery rate \<0.005. In addition, a minimum raw reads of 10 was taken as a threshold for gene expression. The amino acid sequences encoded by the final set of 527 genes were used in conserved domain searches (CD-search NCBI) \[[@CR41]\] and Gene Ontology (GO) database for functional annotation \[[@CR42]\]. A smaller set of highly induced genes was selected using a cut off of a log2 FC ≥ 4. Their annotation was verified manually by comparing mapped reads to the predicted JGI gene models in the Integrative Genomics Viewer (IGV) \[[@CR43]\]. The amino acid sequences of fifteen gene products were corrected and eight genes were excluded from the list due to wrong and currently not correctable (due to low read number) annotation (Supplementary Information SI[2](#MOESM2){ref-type="media"}). The amino acid sequences of 108 genes and the entire *C. cinerea* AmutBmut proteome were investigated for the presence of predicted signal peptides by SignalP v4.1 \[[@CR44]\], and transmembrane domains by TMHMM v.2.0 \[[@CR45]\]. Sequences with one predicted transmembrane domain were analyzed for possible overlap with predicted signal peptides. Overrepresentation of secreted/membrane proteins encoded by induced genes vs the whole proteome was examined using the absolute numbers in a chi-square test with Yates' correction and two-sided *P*-values were obtained. An all-vs-all Blast search (NCBI) using an E-value of 1e-06 was performed to identify proteins encoded by duplicate genes. A cut off of minimal 60% coverage for the longest of the two sequences, at least 30% identity and a minimum bit score of 50 was used. To test the significance of the relative ratios between induced *vs* entire genome, a chi-square test was performed.

qRT-PCR analysis of specific genes {#Sec7}
----------------------------------

To monitor the transcription level of specific *C. cinerea* genes, total cDNA was synthesized from total RNA (see above for extraction protocol) as described previously \[[@CR17]\]. qRT-PCR of specific cDNAs and data analysis was performed as previously described \[[@CR19]\] using the primers listed in Table [S2](#MOESM1){ref-type="media"}.

Alignment and phylogenetic analysis {#Sec8}
-----------------------------------

The sequences of all 6 LYS, 10 DLP proteins and 7 Copsin paralogs were manually verified and corrected, if necessary, using IGV browser \[[@CR43]\]. All the protein sequences that were used in this study are listed in Table [S1](#MOESM1){ref-type="media"}. All the alignments were performed using the ClustalW algorithm (v2.1) \[[@CR46]\].

Cloning, production and purification of Copsin and CPP2 {#Sec9}
-------------------------------------------------------

The codon-optimized prepro-Copsin (CPP1) insert and the native prepro-CPP2 insert were cloned into the pPICZA expression plasmid (Invitrogen) using the restriction enzymes *EcoRI*/*SalI* (Thermo Scientific) \[[@CR47]\]. Both constructs were linearized with *SacI* and transformed into *P. pastoris* by electroporation as described previously \[[@CR15], [@CR48]\].The standard methanol-limited fed-batch procedure was performed in a 3.6 l Labfors 5 bioreactor (Infors) according to the *Pichia* fermentation process guidelines of Invitrogen (Thermo Scientific) and using the process parameters and feed-in strategy as described \[[@CR47]\]. The cells were removed by centrifugation (8000 x g, 20 °C, 20 min) and the resulting supernatant was vacuum filtered (0.22 µm rapid-Filtermax 500; Techno Plastic Products TPP). The solution was diluted to a conductivity of 9--11 mS/cm by adding ddH~2~O and the pH was adjusted to 7 by adding ammonium hydroxide. After vacuum filtration (0.22 µm rapid-Filtermax 500; TPP), the solution was loaded on a self-made SP-Sephadex cation exchange column pre-equilibrated with binding buffer A (20 mM sodium phosphate pH 7, 10 mM NaCl). The column was washed with 17% buffer B (20 mM sodium phosphate pH 7, 1 M NaCl) and the peptide was eluted with 60% buffer B. The peptide elution was monitored at UV absorbance of 210 nm and 280 nm. Fractions containing either the Copsin or the CCP2 peptide were pooled and concentrated in a 2 kDa Spectra/Por dialysis membrane (Spectrum Laboratories) as previously described \[[@CR15]\]. The concentrated eluate was dialyzed against buffer C (2 mM sodium phosphate buffer pH 7.2, 70 mM NaCl) at 4 °C for 24 h. After further concentration in a 6-8 kDa Spectra/Por dialysis membrane (Spectrum Laboratories), the protein solution was again dialyzed against buffer C. The protein concentration was determined by a Pierce BCA protein assay, according to the manufacturer's instructions (Thermo Scientific).

Antimicrobial activity of Copsin and CPP2 {#Sec10}
-----------------------------------------

MIC values were determined by the microdilution broth method according to the Clinical and Laboratory Standards Institute (CLSI) guidelines with minor modifications \[[@CR49]\]. In brief, two-fold dilution series (0.12--64 µg/mL) of Copsin and CPP2 were prepared in 96-well polypropylene microtiter plates in cation-adjusted Mueller-Hinton broth (CAMHB; BD Diagnostics). The tested bacteria (see Fig. [3](#Fig3){ref-type="fig"}) were grown in LB-Lennox medium to an OD~600~ of 0.2--0.6 and added to the dilution series to 10^5^--10^6^ cfu/mL. For *Listeria monocytogenes* and *Corynebacterium diphtheriae*, CAMHB was supplemented with 3% laked horse blood (Oxoid). The plates were incubated at 37 °C for 20 h. Each strain was tested at least in duplicate. The cfu/mL was determined by plating dilutions of the growth control on LB-Lennox agar plates.

Cloning of GH24-type lysozyme genes {#Sec11}
-----------------------------------

cDNA from RNA of induced co-cultures was synthesized using the Transcriptor Universal cDNA Master kit (Roche) and used as template for the amplification of the DNA sequence encoding the protein of LYS1, LYS2 and LYS3 lacking the predicted signal sequences by PCR. Primers are listed in Table [S2](#MOESM1){ref-type="media"} and contained restriction sites for *Eco*RI at the 5' and for *Not*I at the 3' end. The PCR products were ligated into *P. pastoris* expression vector pPICZαA (Invitrogen) using the α-factor as secretion signal. The obtained plasmid containing LYS2 was subsequently used as template for the generation of LYS2His and LYS2His∆N. The polyhistidine sequence was added to the reverse primer to obtain constructs with a C-terminal His6-tag and *Eco*RI and *Not*I restriction sites were used for ligation into pPICZαA. The pPICZαA-LYS2His plasmid was used as template for the generation of LYS2(D131A)His by targeted mutagenesis. Briefly, overlapping forward and reverse primers were designed with a single nucleotide change that results in the required amino acid change. The full plasmid was amplified and the PCR product was digested with *Dpn*I to remove the methylated template plasmid. After on-column cleaning, the plasmid with LYS2(D131A)His was transformed into *E. coli* DH5α for amplification.

GH24-type lysozyme production and purification {#Sec12}
----------------------------------------------

The GH24-type lysozyme-encoding plasmids were linearized with *Sac*I, or for pPICZαA_LYS1 with *Mss*I (*Pme*I), and transformed into *P. pastoris* \[[@CR15], [@CR48]\]. Approved *P. pastoris* transformants were used to inoculate 10 ml BMGY medium (1% (w/v) yeast extract, 2% (w/v) peptone, 1.3% (w/v) YNB without amino acids (BD Diagnostics), 100 mM potassium phosphate buffer pH 6, 1% (v/v) glycerol) and grown at 28 °C for 24 h at 180 rpm. The cells were pelleted by centrifugation (3000×*g*, 5 min, RT (room temperature)), resuspended into a *P. pastoris* minimal medium (1.3% (w/v) YNB without amino acids, 100 mM potassium phosphate buffer pH 6, 0.4 g/mL biotin, 0.5% (w/v) NH4Cl, 1% (v/v) MeOH) and cultured further for 3 days at 28 °C and 180 rpm, during which MeOH was added to 1 % every 12 h.

After centrifugation (3000 × *g*, 10 min, 4 °C), the supernatant was filter sterilized and concentrated using Vivaflow 50 R with a 5 kDa cut off filter membrane (Sartorius AG). For the purification of polyhistidine-tagged proteins, the concentrated medium was dialyzed in a dialysis membrane with a 2 kDa cut off (Spectrum Laboratories) against 2 × 4 L PBS at 4 °C for 24 h. For the non-tagged proteins, the solution was dialyzed against a 20 mM sodium phosphate pH 6.5, 50 mM NaCl buffer (buffer D). His6-tagged proteins were loaded on a PBS-calibrated Ni^2+^-NTA agarose column (Macherey-Nagel), washed with 10 mM imidazole and eluted with 250 mM imidazole in PBS. The non-tagged proteins were loaded on self-made SP-Sephadex cation exchange column equilibrated with buffer D. After washing with buffer D, the proteins were eluted at 200 mM NaCl in 20 mM Na-phosphate buffer pH 6.5. For all proteins, after elution from the column, the elution buffer was exchanged to PBS using PD-10 columns (GE Healthcare). Protein concentrations were determined using the Pierce BCA protein assay kit (Thermo Scientific).

Lysozyme activity assays {#Sec13}
------------------------

*B. subtilis* 168 \[[@CR50]\], *Staphylococcus aureus* 113 (DSMZ 4910) and *Staphylococcus carnosus* 361 (DSMZ 20501) were grown in LB medium at 37 °C to an OD~600~ of 2. *Micrococcus luteus* (DSMZ 20030) was cultivated in nutrient broth (Difco, BD Diagnostics) at 28 °C to an OD~600~ of 2. Cells were harvested by centrifugation (6000 rpm, 5 min, RT), washed with 66 mM potassium phosphate buffer pH 6.2 and resuspended in the same buffer to an OD~600~ of 100 and frozen in small aliquots. Upon use, potassium phosphate buffer was added to obtain a starting OD~600~ of 1 and aliquots of 100 µL of the cell suspension were transferred into a 96-well microtiter plate (Tissue culture test plate 96F; TPP). Lysozymes and BSA were added to a final concentration of 20 µg/mL in a total volume of 102 µL. The cells were incubated in the microplate reader (Infinite 200 PRO; Tecan), shaking (orbital, 4 mm amplitude) at 37 °C, and the OD~450~ was measured in a time interval of 5 min, for 60 min (*B. subtilis* and *M. luteus*), or 120 min (*S. aureus* and *S. carnosus*).

Results {#Sec14}
=======

*C. cinerea* responds to *E. coli* and *B. subtilis* with induction of highly overlapping gene sets {#Sec15}
---------------------------------------------------------------------------------------------------

The response of the fungus *C. cinerea* towards two different types of bacteria, Gram-positive and Gram-negative, was investigated exploiting a previously described experimental setup for cocultivation of fungi and bacteria \[[@CR15], [@CR51]\], for comparative transcriptomics and proteomics. This setup involved cultivation of *C. cinerea* strain AmutBmut vegetative mycelium on glass beads submerged in liquid minimal medium to which either the Gram-negative bacterium *E. coli* Nissle 1917 or the Gram-positive species *B. subtilis* NCIB 3610 was added. *C. cinerea* mycelium was harvested for transcriptome analysis after 8 h of co-cultivation, during which time the OD~600~ of *E. coli* increased from 0.1 at the time of bacterial inoculation, to 0.127 (±0.017). The density of *B. subtilis* cells decreased during co-cultivation, probably due to the production of Copsin \[[@CR15]\], resulting in an average OD~600~ of 0.012 (±0.001) at the time of mycelial harvesting. Differential expression of annotated protein-encoding *C. cinerea* genes was assessed by comparing DESeq2 normalized read values in *E. coli*-exposed or *B. subtilis*-exposed mycelium to untreated mycelium. Comparing *E. coli*-induced and *B. subtilis*-induced genes (log2 FC ≥ 2, FDR \< 0.005) revealed that in the presence of *E. coli*, a higher number of *C. cinerea* genes (510 genes, 3.6% of the predicted proteome) were induced than in the presence of *B. subtilis* (165 genes, 1.2% of the predicted proteome) (Supplementary Information SI[2](#MOESM2){ref-type="media"}). Interestingly, 90% of the *B. subtilis*-induced genes are also induced by *E. coli*. This overlap comprises predominantly the *E. coli*-induced genes with the highest FC (Fig. S[1](#MOESM1){ref-type="media"}). We selected a smaller set of highly induced genes, using a cut off of log2 FC ≥ 4 and FDR \< 0.005 for detailed analysis and identification and characterization of potential fungal defense genes (Supplementary Information SI[2)](#MOESM2){ref-type="media"}. The differential expression of five of these genes and one non-induced gene as control was confirmed by qRT-PCR (Fig. S[6](#MOESM1){ref-type="media"}). Using the same cut off, log2 FC ≥ 4 and FDR \< 0.005, the expression of only ten and no genes was found to be downregulated in the presence of *E. coli* and *B. subtilis*, respectively. These genes were not further investigated.

*C. cinerea* genes with induced expression in response to bacteria tend to cluster and to occur in multi-gene families {#Sec16}
----------------------------------------------------------------------------------------------------------------------

Inspection of the genomic location of the bacteria-induced set of 108 genes (log2 FC ≥ 4) revealed that many of these genes cluster. Although the incomplete assembly of the *C. cinerea* AmutBmut genome makes it difficult to perform a thorough analysis, we found that 62 of the 108 induced genes colocalize with one or more other induced gene(s) within a genomic region of maximum 100 kb. Of these 62 genes, 28 genes are located adjacent to each other or separated by a maximum of two open reading frames and 10 genes represent pairs of paralogous genes that are adjacent to each other (Fig. [1a](#Fig1){ref-type="fig"}). Clustering of bacteria-induced genes is exemplified by a 120 kb genomic region containing 48 protein-encodinggenes, in which six bacteria-induced genes were found (Fig. [1b](#Fig1){ref-type="fig"}). These genes encode an adenylate-forming reductase \[[@CR52]\], a ferredoxin reductase, a major facilitator superfamily (MFS) transporter, a lysozyme and two paralogous hypothetical proteins (HPs). Despite their clustering, these genes do not seem to constitute a classical gene cluster where the gene products function in the same (metabolic) pathway. Interestingly, however, we found an induced gene cluster where two bacteria-induced cytochrome P450 encoding genes flank a gene encoding a sesquiterpene synthase. The latter gene is the most highly induced gene in both *E. coli* and *B. subtilis*-exposed mycelium. This classical gene cluster has previously been functionally characterized and the encoded enzymes were proposed to be responsible for the production of the antimicrobial quinone sesquiterpenoid lagopodin \[[@CR53]\].Fig. 1Clustering of bacteria-induced genes in the *C. cinerea* genome. **a** Occurrence of different degrees of gene clustering. More than 50% of the 108 most highly induced genes were found to cluster; either within a larger chromosomal region of 100 kb or adjacent to each other (with a maximum of two genes in between). Paralogous genes are more likely to cluster and are therefore categorized separately. **b** Example illustrating the three degrees of clustering of bacteria-induced genes (marked with arrows), with the two hypothetical proteins (HPs) representing paralogs with 69% amino acid sequence identity. The respective JGI protein IDs are as follows: adenylate-forming reductase, 361483; MFS transporter, 559285; GH24-type lysozyme, 442447; HPs, 442449 and 559271; Ferredoxin reductase, 361411). Notion on the dimension of the indicated numbers of (protein-encoding) genes: The *C. cinerea* genome is predicted to encode 14242 proteins according to the JGI MycoCosm (May 2018) \[[@CR83]\]. Thus, the proteins encoded by 142 genes roughly represent 1% of the predicted proteome

We noticed that many bacteria-induced *C. cinerea* genes do not only cluster but also have paralogs. Since the *C. cinerea* genome is rich in gene duplications \[[@CR54]\], we investigated whether genes belonging to multi-copy gene families would be overrepresented in the bacteria-induced gene set. In an all-versus-all blast search (NCBI) we identified 4731 out of 14242 (33%) *C. cinerea* AmutBmut genes that have one or more duplicates, whereas a significant overrepresentation of 67 out of 108 (62%) of the bacteria-induced genes are part of multi-gene families (*P* \< 0.0001) (Fig. [2a](#Fig2){ref-type="fig"} and Supplementary Information SI[2](#MOESM2){ref-type="media"}). In some gene families, multiple members are induced by the presence of bacteria (Fig. [2b](#Fig2){ref-type="fig"}). For example, the genome of *C. cinerea* encodes for a gene family of three adenylate-forming reductases that might be involved in secondary metabolite synthesis \[[@CR52]\], and two of the(se) genes are induced in the presence of bacteria. Other induced genes might encode proteins that contain the same predicted conserved domain, but belong to different families (Fig. [2b](#Fig2){ref-type="fig"}) as the family classification is based on overall sequence similarity rather than the presence of a domain. For example, four induced genes encode for proteins that are all predicted to be MFS transporters but they belong to different gene families due to low sequence similarity with each other. MFS transporters may be involved in the export of antibiotics produced by *C. cinerea* or of antifungal compounds produced by bacteria out of the fungal cell \[[@CR55]\]. Taken together, we found that bacteria-induced *C. cinerea* genes are not randomly distributed in the genome and that multi-copy genes are overrepresented.Fig. 2Overrepresentation of multi-copy genes and genes encoding secreted proteins among bacteria-induced genes. **a** Relative numbers of single copy or duplicate genes among all *C. cinerea* genes or the bacteria-induced genes with a log2 FC ≥ 4. **b** Representation of bacteria-induced genes being part of a multi-gene family and/or encoding predicted secreted proteins. Protein annotation is based on the identification of conserved domains (CD search NCBI) and putative functions related to bacterial-fungal interaction were assigned. The same annotation may occur multiple times in case multiple induced genes encode proteins with the same conserved domain but categorize in different gene families due to low overall similarity, e.g., GH24-type lysozyme 1-5 and 6. For bacteria-induced multi-copy genes, the total number of genes in the gene family is indicated in the inner circle (copy \#). The colors in the second circle indicate how many genes of this family are bacteria-induced with a log2 FC ≥ 4 (\# ind). The predicted localization (Prot loc) of the encoded proteins is represented in the outer circle. The white numbers indicate the number of secreted proteins of the respective family that were identified in the *E. coli*-induced secretome. **c** Relative numbers of all *C. cinerea* proteins and the proteins encoded by bacteria-induced genes (log2 FC ≥ 4) that are predicted to be cytoplasmic, membrane-bound (TMHMM2.0) or secreted (SignalP4.1). **a**, **c** *P*-values are calculated by chi-square tests using numerical values. FC fold change, HP for hypothetical protein, MFS for major facilitator superfamily, DUF for domain of unknown function, GFA for glutathione-dependent formaldehyde-activating

*C. cinerea* responds to bacteria by the secretion of proteins with predicted antibacterial activity {#Sec17}
----------------------------------------------------------------------------------------------------

Induced *C. cinerea* genes encoding secreted proteins were of particular interest, as these proteins might directly interact with bacteria and possibly possess antibacterial activity \[[@CR8]\]. For this reason, the predicted localization of proteins, encoded by the set of the 108 most highly induced genes, was examined. A comparison with the predicted localization of all *C. cinerea* proteins revealed a significant overrepresentation of secreted proteins in the induced gene set (*P* \< 0.0001) (Fig. [2c](#Fig2){ref-type="fig"}). Most of the 44 predicted secreted proteins do not contain a conserved domain (CD search, NCBI), and 20 of the proteins are smaller than 250 amino acids. These hypothetical proteins (HPs) resemble the small secreted proteins (SSP) that are produced by pathogenic and symbiotic fungi during host colonization as effectors to modulate the host and often lack homology to other proteins \[[@CR56], [@CR57]\]. The induced expression of a significant number of genes coding for SSP-like proteins suggests that these proteins play a role as effectors in the interaction of *C. cinerea* with bacteria.

Interestingly, most secreted proteins containing a conserved domain (CD search NCBI) (Fig. [2b](#Fig2){ref-type="fig"}), could be assigned a putative function related to fungal or bacterial cell walls. For example, one protein (JGI protein ID, 422563) contains two Lysin motifs (LysM) and resembles LysM effectors of plant-pathogenic fungi which were demonstrated to bind fungal cell wall chitin \[[@CR58]\]. Related to chitin is also the putative function of a chitin deacetylase (JGI protein ID, 440521), likely involved in conversion of chitin to chitosan. Furthermore, three laccase encoding genes (JGI protein IDs, 502564, 208308, 488706) were found to be induced; fungal laccases have been implicated in stress protection through their involvement in melanin synthesis, but also through degradation of antifungal compounds produced by bacteria \[[@CR59]\] (Fig. [2b](#Fig2){ref-type="fig"}). The bacterial cell wall is the likely target of *C. cinerea* proteins containing a glycoside hydrolase 24 (GH24; PFAM 00959; phage lysozyme) domain (see below). Another family of ten genes, five of which are induced by bacteria, encode small secreted proteins with a length of around 100 amino acids with a conserved pattern of twelve cysteine residues. The amino acid sequence of these proteins do not indicate a conserved domain, but homology modeling using PHYRE2 \[[@CR60]\] predicts a defensin-like fold, consisting of an α-helix and two antiparallel β-strands stabilized by disulfide bonds. Based on previous studies of fungal Csαβ-defensins \[[@CR15], [@CR61], [@CR62]\], we hypothesize that these proteins have antibacterial activity via interactions with the bacterial cell wall and designate these *C. cinerea* proteins defensin-like peptides (DLPs). Interestingly, the bacteria-induced gene set also was found to contain a paralog of a gene that encodes for the previously characterized antibacterial Csαβ-defensin Copsin \[[@CR15]\].

To verify whether the differential transcription of genes encoding secreted proteins is also reflected on protein level, we investigated the differential (cultivated with and without bacteria) secretome of *C. cinerea* on protein level by comparative proteomics (see Supplementary information SI[1](#MOESM1){ref-type="media"} for experimental details). To this end, the proteins in the culture supernatant of *C. cinerea* axenic cultures and co-cultures with *E. coli* were analyzed. Based on our analysis, a total of 23 *C. cinerea* proteins were more abundant in the presence of *E. coli* compared to the control (FC ≥ 4) (Fig. [2b](#Fig2){ref-type="fig"} and S[2](#MOESM1){ref-type="media"}), of which 13 proteins are encoded by genes that are bacteria-induced (FC ≥ 4) (Supplementary Information SI[3](#MOESM3){ref-type="media"}). In addition, four more proteins (three DLPs and one chitin deacetylase) that are encoded by family members of bacteria-induced genes, are more abundant by a FC ≥ 2.

Bacteria-induced member of the *C. cinerea* Csαβ-defensin family has the same antibacterial activity profile as Copsin {#Sec18}
----------------------------------------------------------------------------------------------------------------------

To investigate the role of induced secreted proteins as antibacterial defense effectors of *C. cinerea*, bacteria-induced members of the Csαβ-defensin and GH24-type lysozyme families were produced in *P. pastoris* and the antibacterial activity of the recombinant peptides and proteins was evaluated.

We previously identified and characterized an antibacterial Csαβ-defensin, termed Copsin, produced by *C. cinerea* by activity-based fractionation of the fungal secretome \[[@CR15]\]. Copsin is active against Gram-positive bacteria and targets peptidoglycan biosynthesis via binding to the lipid II precursor \[[@CR47]\]. The production of Copsin in vegetative mycelium of *C. cinerea* was found to be constitutive i.e., not modulated by the presence of bacteria (Fig. S[3A](#MOESM1){ref-type="media"}). In contrast, a Copsin paralog that was highly induced upon exposure to bacteria, was identified. This gene was found to be located adjacent to the Copsin-encoding gene and was termed Copsin-paralogous peptide 2 (*cpp2*). Additional BLAST search revealed that *C. cinerea* encodes for a family of 7 Copsin-paralogous peptides with a predicted Csαβ-defensin fold, of which only the gene encoding for CPP2 showed induced expression upon bacterial challenge (Fig. [3a--c](#Fig3){ref-type="fig"}; Fig. S[3A](#MOESM1){ref-type="media"}). Determination of the minimal inhibitory concentrations (MICs) of recombinant CPP2 revealed an antibacterial activity profile that was highly similar to the profile of Copsin (Fig. [3d](#Fig3){ref-type="fig"}). These results suggest that *C. cinerea* is able to fortify the constitutive antibacterial activity of Copsin through induced production of a Copsin-paralog upon exposure to bacteria. Moreover, this finding demonstrates that the expression pattern of duplicated genes can significantly diversify while the function of the encoded proteins is preserved.Fig. 3Overview of Copsin-paralogous peptides (CPPs) encoded in the genome of *C. cinerea*. **a** Premature Copsin (CPP1) and its paralogs (CPP2-6) consist of a signal peptide (SP), a pro-peptide and a mature peptide of 57 to 65 amino acids. **b** The mature peptides show a conserved N-terminal glutamine and a characteristic cysteine pattern of 12 residues, which are indicated with red arrows. The sequences were aligned using the ClustalW algorithm (v2.1). **c** Relative expression of the genes coding for Copsin and its paralogs in the presence of *E. coli* or *B. subtilis* compared to the axenic control. Asterisks indicate log2 FC ≥ 2 and FDR value \<0.005. DeSeq2 normalized counts were placed in Fig. S[3A](#MOESM1){ref-type="media"}. **d** Minimal inhibitory concentrations (MICs; µg/ml) of Copsin and its paralog CPP2 for different bacteria. The values were determined using to the microdilution broth method \[[@CR49]\]

Bacteria-induced members of the *C. cinerea* GH24-type lysozyme family lyse bacterial cells {#Sec19}
-------------------------------------------------------------------------------------------

The genome of *C. cinerea* encodes for six paralogs of GH24-type lysozymes (Fig. [4](#Fig4){ref-type="fig"}, S[3](#MOESM1){ref-type="media"} and S[4](#MOESM1){ref-type="media"}). The archetype of this type of lysozyme is the T4 lysozyme, also referred to as phage endolysin or lysin \[[@CR63], [@CR64]\]. It hydrolyzes the β-1,4 glycosidic bond of peptidoglycan (PGN) in the bacterial cell wall for the release of the T4 phages \[[@CR65]\]. The expression of three *C. cinerea* GH24-type lysozyme-encoding genes, termed *lys1-3*, was found to be highly induced in the presence of bacteria (Fig. [4c](#Fig4){ref-type="fig"}). In agreement with this finding, LYS1 and LYS2 were also found in the *E. coli*-induced secreted proteome (Supplementary Information SI[3](#MOESM3){ref-type="media"}).Fig. 4*C. cinerea* encodes a family of GH24-type lysozymes (LYS) and defensin-like peptides (DLPs). **a** DLPs are composed of a signal peptide (SP) and a domain enriched with 12 cysteine residues as found in copsin and paralogs (Fig. [3](#Fig3){ref-type="fig"} and Fig. S[3B](#MOESM1){ref-type="media"}). This cysteine-rich domain was also identified in secreted lysozymes, which is then attached over a linker-peptide to a C-terminal glycosyl hydrolase (GH24) domain (Fig. S[3B](#MOESM1){ref-type="media"} and Fig. S[4](#MOESM1){ref-type="media"}). **b** A sequence alignment of the lysozyme domain of LYS1-3 revealed conserved catalytic residues (red arrows) characteristic for the GH24-type lysozyme family with T4 lysozyme (PDB: 2LZM) as a founding member \[[@CR33], [@CR65]\]. The alignment was performed using the ClustalW algorithm (v2.1). The GH24 domain was assigned by the BlastP algorithm according to the LYS2 sequence and is marked with a green dashed line. **c** Relative expression of LYS- and DLP-encoding genes in the presence of *E. coli* or *B. subtilis* compared to the expression in the axenic control as determined by RNA sequencing. The dashed line and asterisks indicate the cut off of log2 FC ≥ 2 and FDR value of \<0.005, respectively. DeSeq2 normalized counts were placed in Figure [S3C](#MOESM1){ref-type="media"}. *lys4*, *lys5*, and *dlp8* are not included in the histograms due to their low level of expression (\<10 reads/locus)

Alignment of the sequences of all six *C. cinerea* GH24-type lysozymes revealed that five proteins contain a conserved cysteine-rich N-terminal domain, while the N-terminus of LYS6 is different and contains repetitive sequences (Fig. S[4](#MOESM1){ref-type="media"}). Intriguingly, the amino acid sequence of this N-terminal domain, in particular the pattern of the twelve conserved Cys-residues, is homologous to the amino acid sequence of the DLPs described above and most likely adopts a defensin-like fold which is stabilized by up to six disulfide bridges (Fig. [4a](#Fig4){ref-type="fig"} and Fig. S[3B](#MOESM1){ref-type="media"}). Thus, the *C. cinerea* genome encodes five GH24-type lysozymes (Table [S1](#MOESM1){ref-type="media"}, LYS1-5) and ten DLPs (Table [S1](#MOESM1){ref-type="media"}, DLP1-10) which share a defensin-like domain. These gene families have most likely arisen via gene fusion, multiplication and diversification. The bacteria-induced expression of several members of these gene families suggests a role of the encoded proteins and peptides in the interaction with bacteria.

In order to test the activity of defensin-like domain-containing lysozymes against bacteria, LYS1, LYS2, and LYS3 were produced in *P. pastoris*, purified (Fig. S[5A](#MOESM1){ref-type="media"}) and tested for their ability to lyse bacterial cells. Analogous attempts to heterologously produce DLPs or isolated defensin-like domains of the identified fungal lysozymes were not successful. For the lysis assays, stationary bacterial cells were suspended in phosphate buffer in a 96-well microtiter plate and incubated with the recombinant lysozymes. Hen egg white lysozyme (HEWL) was used as positive and bovine serum albumin (BSA) as negative control. Optical density at 450 nm of the suspensions was measured over 60 to 120 min.

In case of *B. subtilis*, the three tested *C. cinerea* lysozymes showed lysis kinetics very similar to HEWL, with a rapid decrease in optical density between 10 and 20 min (Fig. [5a](#Fig5){ref-type="fig"}). In the assays with *M. luteus (lysodeikticus)*, which is known for its susceptibility to lysozyme activity \[[@CR66]\], LYS1 showed significantly reduced cell lysis activity compared to LYS2 and LYS3 (Fig. [5d](#Fig5){ref-type="fig"}). We further investigated this difference by incubating fluorescently labeled *M. luteus* cell wall preparations (EnzCheck, Thermo Scientific) with a concentration series of the lysozymes and subsequent measuring of released fluorescence due to cleavage of *M. luteus* PGN. In accordance with the cell-based assay, no fluorescence above background level was detected in this assay upon incubation with LYS1, whereas incubation with LYS2 and LYS3 resulted a concentration-dependent release of fluorescence (Fig. [5g](#Fig5){ref-type="fig"}). The inability of LYS1 to cleave *M. luteus* PGN and its drastically reduced *M. luteus* cell lysis activity suggested a significant difference in substrate specificity between this lysozyme and the other two paralogs. To further assess the lysozyme specificity for Gram-positive bacteria, we performed the bacterial cell lysis assays with *Staphylococcus carnosus* and *S. aureus* (Fig. [5c, f](#Fig5){ref-type="fig"}). In contrast to *S. carnosus*, *S. aureus* is known to O-acetylate its PGN, which contributes to resistance towards PGN cleavage by most lysozymes such as the HEWL-type \[[@CR67]\]. Although less rapidly than observed for *M. luteus* or *B. subtilis*, *S. carnosus* cells lysed in the presence of LYS2 and LYS3, but not in the presence of LYS1. In contrast, incubation with neither of the *C. cinerea* lysozymes resulted in *S. aureus* cell lysis. Taken together, these results demonstrate that *C. cinerea* lysozymes have the ability to lyse bacterial cells and that this activity is likely based on different modes of action on different bacterial species.Fig. 5Activity of *C. cinerea* GH24-type lysozymes on Gram-positive bacteria. **a**--**f** Bacterial cell lysis activity was determined in a microtiter plate turbidity assay for *B. subtilis*, *M. luteus*, *S. carnosus* and *S. aureus*. Cells were treated with the following proteins at a concentration of 20 µg/ml: Untagged recombinant lysozymes (LYS1-3), His6-tagged LYS2 (LYS2His), His6-tagged lysozyme domain of LYS2 (LYS2His∆N), His6-tagged catalytic mutant LYS2 (LYS2(D131A)His), hen egg white lysozyme (HEWL) as positive and bovine serum albumin (BSA) as negative control. The bacterial suspensions were incubated at 37 °C and data points were acquired at an optical density of 450 nm in 5 min time intervals. The average of three biological replicates is shown together with the standard deviation. **g** Lysozyme activity was determined using the EnzChek Lysozyme assay kit (Thermo Scientific). 4-fold dilution series of the proteins listed above were incubated with *M. luteus* fluorescein-labeled cell wall. The release of fluorescein due to hydrolysis of cell wall was measured after 30 min of incubation at 37 °C with excitation and emission wavelengths of 485 nm and 535 nm, respectively. Each data point represents the average of three replicates. Error bars indicate standard deviation

The contribution of the defensin-like domain and the predicted active site residues to the bacterial cell lysis activity of the *C. cinerea* lysozymes was assessed by producing variants of LYS2. Full-length LYS2 (LYS2His), truncated LYS2 containing only the lysozyme domain (LYS2His∆N) and a presumptive LYS2 catalytic mutant (D131A) (Fig. S[5](#MOESM1){ref-type="media"}) were produced with a C-terminal His6-tag in *P. pastoris* and purified using metal chelate chromatography. LYS2His∆N lysed *B. subtilis* and *M. luteus* cells as efficiently as full length LYS2His (Fig. [5b, e](#Fig5){ref-type="fig"}). In contrast, the LYS2(D131A)His mutant did not cause lysis of *B. subtilis* or *M. luteus* (Fig. [5b, e](#Fig5){ref-type="fig"}). In agreement with these results, LYS2His and LYS2His∆N cleaved *M.luteus* PGN in the EnzChek lysozyme assay, whereas the LYS2(D131A)His mutant did not (Fig. [5g](#Fig5){ref-type="fig"}). In conclusion, the results indicate that the N-terminal DLP domain of the lysozyme does not contribute to bacterial lysis and peptidoglycan hydrolysis activity of LYS2 whereas the predicted active site residue D131 was critical for these activities.

Discussion {#Sec20}
==========

The defense mechanisms employed by fungi to cope with competing or antagonistic bacteria are poorly understood. While fungi are notorious producers of antibacterial compounds, it is not clear whether these compounds can be produced as part of a specific defense response against bacteria. In the present study, results of transcriptome and secretome analyses demonstrate that bacteria induce an antibacterial response in the fungus *C. cinerea*. This response predominantly relies on secreted proteins, of which many are predicted or shown to have antibacterial activity. The majority of the secreted proteins found in the induced secretome or encoded by bacteria-induced genes are smaller than 250 amino acids and lack annotated domains, which complicates functional predictions. These characteristics are reminiscent of effector proteins that are produced by fungal pathogens and endophytes, as well as mycorrhizal fungi during plant colonization to establish fungal growth in the host \[[@CR68]--[@CR70]\]. An overrepresentation of genes encoding small secreted proteins (SSPs) was also found among *P. anserina* genes that were induced upon exposure to two bacterial *Serratia* species, one of which kills the fungus \[[@CR26]\]. Therefore, it appears that the secretion of SSPs plays a significant role in the interaction of fungi with plants and bacteria, including mutualistic, pathogenic, or competitive interactions.

In previous interaction studies, the confrontation between fungi and bacteria was mostly done on agar plates, often without physical contact of the organisms \[[@CR23], [@CR24], [@CR26]\]. In this study we used a semi-liquid setup, in which we cultivated *C. cinerea* on submerged glass beads \[[@CR15], [@CR51]\]. This setup allowed motile bacteria, when added to the liquid phase, to interact with the mycelium in a dynamic and intimate manner. Moreover, this experimental system allowed us to analyze the gene expression of *C. cinerea* in response to bacteria on both transcriptome and secreted proteome level as secreted proteins could be easily retrieved from the liquid phase. These analyses revealed a relatively large number of genes with a high level of induction under these conditions.

Many of the bacteria-induced genes in the genome of *C. cinerea* are clustered. On the one hand, this is explained by tandem gene duplications. Gene duplication resulting in expansion of (effector) gene families has been described for fungal pathogens and may facilitate evolution of new protein functions due to functional redundancy \[[@CR71], [@CR72]\]. One prominent example is the bacteria-induced gene *cpp2* which is localized next to the paralogous gene *cpp1* coding for the previously described antibacterial Csαβ-defensin Copsin \[[@CR15]\]. On the other hand, clustering of non-homologous but functionally related genes is known from secondary metabolite biosynthesis in fungi \[[@CR73]\]. It is hypothesized that clustering minimizes meiotic recombination between and/or facilitates coregulation of these genes \[[@CR74], [@CR75]\]. The above mentioned example of the *cpp2* and *cpp1* gene tandem, however, shows that duplicated genes can differ considerably in their expression pattern since *cpp1* is expressed constitutively under the applied conditions. Since CPP2 and Copsin are functionally redundant regarding their antibacterial activity, this special regulation pattern implies a mechanism where a Csαβ-defensin-mediated, constitutive defense of *C. cinerea* against bacteria is fortified in response to bacterial challenge. Genes coding for Csαβ defensins (of different classes) have recently been identified in a wide range of fungal genomes and, based on characterized antibacterial activities thus far, might be part of a general defense of fungi against bacteria \[[@CR61], [@CR62], [@CR76]--[@CR78]\]. Accordingly, structural modeling predicts additional defensin-like proteins among our set of bacteria-induced, non-annotated *C. cinerea* proteins. These predictions are currently tested by heterologous expression of these proteins and analysis of their structure and function.

Bacteria-induced genes in *C. cinerea* also tend to belong to expanded gene families. This phenomenon is exemplified by the identification of a family of Copsin paralogs in *C. cinerea* (Fig. [3](#Fig3){ref-type="fig"}). Other examples are two families of *C. cinerea* proteins containing a defensin-like domain, either as single domain in defensin-like proteins (DLPs) or N-terminal of a GH24-type lysozyme domain. Both DLPs and GH24-type lysozymes are encoded by expanded gene families of ten and five genes, respectively. Detailed analysis of the expression and the function of individual family members suggests that these proteins play a significant role in the interaction with bacteria. Lysozymes with a GH24 domain belong to the phage lysozyme family and supposedly have muramidase activity, i.e., hydrolysis of the glycosidic bond between GlcNAc and MurNAc \[[@CR79]\]. Despite the predicted muramidase activity, heterologously produced *C. cinerea* LYS1 was, in contrast to LYS2 and LYS3, not able to hydrolyze fluorescently labeled *M. luteus* cell wall material (Fig. [5g](#Fig5){ref-type="fig"}). In agreement with this observation, LYS1 was also less efficient in lysing *M. luteus* (Fig. [5d](#Fig5){ref-type="fig"}) and failed to lyse *S. carnosus* cells (Fig. [5c](#Fig5){ref-type="fig"}). These differences in activity suggests that *C. cinerea* lysozymes have functionally diverged. The activity of LYS2 appears to be dependent on its enzymatic function as mutation of the predicted active site residue (D131A) abolishes all activities (Fig. [5b, e, g](#Fig5){ref-type="fig"}). In addition, the cell lysis activity of the three *C. cinerea* lysozymes appears to be dependent on the acetylation of PGN since *S. aureus* cells could not be lysed by any of the analyzed recombinant proteins (Fig. [5f](#Fig5){ref-type="fig"}). The function of the defensin-like domain of the lysozymes remains unclear as deletion of this domain did not have a significant effect on the activity of LYS2 in the cell lysis or cell wall material hydrolysis assays (Fig. [5b, e, g](#Fig5){ref-type="fig"}). Although we could not assess the antibacterial activity of the DLPs, the identification of four *dlp*s in bacteria-induced transcriptome and three DLPs in the *E. coli*-induced secretome strongly suggests that these proteins play a significant role in the interaction of *C. cinerea* with bacteria. To our knowledge, there is no precedence for such a dual appearance of a defensin-like domain in any organism. Conversely, although the distribution of proteins that consist of a defensin-like domain fused to a lysozyme domain is restricted to a few fungal species, the occurrence of the GH24-type lysozyme domain is widespread in the fungal kingdom. Therefore, it is hypothesized that, in other fungal species, proteins with similar (catalytic) functions as the characterized *C. cinerea* LYS proteins, but with a different domain organization, play a similar role in antibacterial defense.

The overlap between the induced *C. cinerea* genes upon challenge with either Gram negative *E. coli* or Gram positive *B. subtilis* was particularly evident among the most highly induced genes. Overlapping responses of the fungal plant pathogenic basidiomycete *Rhizoctonia solani*, as well as of the coprophilous ascomycete *Podospora anserina* to bacterial *Serratia* species of different levels of antagonism, were reported recently \[[@CR24], [@CR26]\]. These results suggest that fungi do not differentiate between different bacteria and mount a rather general defense response that leads to the secretion of an arsenal of molecules affecting the growth of different types of bacteria e.g., by targeting conserved bacterial structures. Accordingly, two of the characterized defense effectors, Csαβ-defensins and GH24-type lysozymes fused to a defensin-like domain, affect peptidoglycan, a conserved constituent of the bacterial cell wall. The induction of genes with putative antifungal functions (LysM, chitinase, chitin deacetylase) in this study may indicate though that the fungus cannot differentiate between bacteria and fungi. Despite the apparent lack of specificity of the fungal defense response with regard to different types of microbial competitors, the lack of significant overlap between the transcriptional response of *C. cinerea* to fungivorous nematodes and to bacterial competitors on agar plates \[[@CR19]\] suggests that this fungus is able to discriminate between these two types of antagonists and to induce an antagonist-specific transcriptional response. It is currently not clear, however, how widespread this capability is in the fungal kingdom. Also the physiological significance of the antibacterial response of the fungus upon bacterial challenge is not clear since the fungus could use the secreted antibacterial proteins either as defense molecules to protect itself from damage or as predatory molecules to gain additional nutrients.

The molecular basis of the antagonist-specific responses of the fungus is currently unknown. Future experiments will address the questions whether the antibacterial response of *C. cinerea* is elicited by a single or multiple signals, whether the signal(s) is(are) of bacterial or fungal (produced by bacterial enzymes) origin, whether the signal(s) is (are) on the surface of the microbial cells or shed into the culture supernatant and, finally, whether Gram-positive and Gram-negative bacteria are recognized via the same signal(s) and respective fungal receptor(s) or whether specific recognition pathways exist that lead to activation of the same response. Candidate microbe-associated molecular patterns (MAMPs) that are common between the two types of bacteria, are peptidoglycan fragments (muropeptides). These compounds have been shown to be steadily shed into the medium during bacterial growth and to elicit responses in bacteria, animals and plants and even fungi via cell surface or intracellular receptors \[[@CR80], [@CR81]\]. Comparative genomics suggests that fungi lack cell surface Toll-Like Receptors (TLRs) and rely entirely on intracellular Nucleotide oligomerization domain-Like Receptors (NLRs) for defense \[[@CR82]\]. The experimental evidence for this hypothesis, however, is rather weak so far and it remains to be seen whether the antibacterial response of *C. cinerea* is mediated via such receptors. Elucidation of these molecular details will help to advance the general knowledge about the innate defense system of fungi which lags far behind the one of plants and animals.

Electronic supplementary material
=================================

 {#Sec21}

Supplementary Information 1 Supplementary Information 2 Supplementary Information 3

Electronic supplementary material
=================================

The online version of this article (10.1038/s41396-018-0293-8) contains supplementary material, which is available to authorized users.

We would like to thank the Functional Genomics Center Zürich, in particular Dr. Weihong Qi, for technical support. We are grateful to Dr. Andrea Sánchez-Vallet for proofreading and discussions and to Dr. Jerome Collemare for technical assistance and proofreading. This work was supported by ETH Zürich (ETH Zürich Postdoctoral Fellowship to A.K. and Grant ETH-45 16-1) and the Swiss National Science Foundation (Grant 31003A_149512).

The authors declare that they have no conflict of interest.
